Understanding symptom contribution to sex inequality in bladder and renal cancer stage at diagnosis
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | Yin Zhou, Georgios Lyratzopoulos, Prabhakar Rajan, Fiona M. Walter, Jianhua Wu |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2024
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
par: Arjun Pon Avudaiappan, et autres
Publié: (2024)
par: Arjun Pon Avudaiappan, et autres
Publié: (2024)
Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
par: Hugo Klempfner, et autres
Publié: (2024)
par: Hugo Klempfner, et autres
Publié: (2024)
The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
par: Kunal K. Sindhu, et autres
Publié: (2024)
par: Kunal K. Sindhu, et autres
Publié: (2024)
Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
par: Mohammed Al‐Zubaidi, et autres
Publié: (2024)
par: Mohammed Al‐Zubaidi, et autres
Publié: (2024)
Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
par: Muhammad Haider, et autres
Publié: (2025)
par: Muhammad Haider, et autres
Publié: (2025)
Emerging tools for the early detection of prostate cancer
par: Muhammad Haider, et autres
Publié: (2025)
par: Muhammad Haider, et autres
Publié: (2025)
Therapy de‐escalation for testicular cancer (THERATEST): A multi‐centre observational cohort feasibility study of de‐escalation therapies for good prognosis stage II germ cell tumours
par: Nasreen Abdul Aziz, et autres
Publié: (2025)
par: Nasreen Abdul Aziz, et autres
Publié: (2025)
Understanding oncological and sexual function outcomes with gynaecological organ preserving cystectomy in women with bladder cancer; a systematic review
par: Rebecca Martin, et autres
Publié: (2025)
par: Rebecca Martin, et autres
Publié: (2025)
Haematuria cancer risk score as a predictor of muscle‐invasive bladder cancer
par: Serdar Turan, et autres
Publié: (2025)
par: Serdar Turan, et autres
Publié: (2025)
Patient experience of bladder cancer: A data linkage study
par: Snehadhar Shah, et autres
Publié: (2024)
par: Snehadhar Shah, et autres
Publié: (2024)
Predictors of adherence to surveillance cystoscopy for patients with non‐muscle invasive bladder cancer
par: Katherina Y. Chen, et autres
Publié: (2026)
par: Katherina Y. Chen, et autres
Publié: (2026)
Acu‐URO17 is a highly sensitive and specific bladder cancer biomarker
par: Liwu Guo, et autres
Publié: (2024)
par: Liwu Guo, et autres
Publié: (2024)
Perioperative chemotherapy use and related outcomes in muscle‐invasive bladder cancer in Australia
par: Alison Hiong, et autres
Publié: (2025)
par: Alison Hiong, et autres
Publié: (2025)
Incidental crossed fused renal ectopia detected during prostate cancer staging: A photorealistic three‐dimensional rendering
par: Kei Ushijima, et autres
Publié: (2025)
par: Kei Ushijima, et autres
Publié: (2025)
Treatment preferences of patients with muscle invasive bladder cancer: A discrete choice experiment
par: Liam Mannion, et autres
Publié: (2024)
par: Liam Mannion, et autres
Publié: (2024)
Novel neoadjuvant therapies for muscle‐invasive bladder cancer: Systematic review and meta‐analysis
par: Shugo Yajima, et autres
Publié: (2025)
par: Shugo Yajima, et autres
Publié: (2025)
Preoperative FAN score predicts survival outcomes after radical cystectomy for bladder cancer
par: Yu Ishizuya, et autres
Publié: (2026)
par: Yu Ishizuya, et autres
Publié: (2026)
Germline homologous recombination repair (gHRR) variants in bladder cancer: Preliminary evidence and clinical implications
par: Rodolfo Hurle, et autres
Publié: (2025)
par: Rodolfo Hurle, et autres
Publié: (2025)
Lymph node dissection during cystectomy for non‐muscle‐invasive bladder cancer: A systematic review
par: Sean Lim, et autres
Publié: (2026)
par: Sean Lim, et autres
Publié: (2026)
Racial and socioeconomic disparities from time of diagnosis to treatment for small renal masses
par: Lila G. McGrath, et autres
Publié: (2026)
par: Lila G. McGrath, et autres
Publié: (2026)
Time toxicity of intravesical BCG versus sequential intravesical gemcitabine and docetaxel for non‐muscle‐invasive bladder cancer
par: Jacob Hanna, et autres
Publié: (2026)
par: Jacob Hanna, et autres
Publié: (2026)
Long non‐coding RNAs define favourable biology in high‐risk non‐muscle‐invasive bladder cancer
par: Rachel Weng, et autres
Publié: (2025)
par: Rachel Weng, et autres
Publié: (2025)
Understanding the long‐term impact of the COVID‐19 pandemic on non‐muscle‐invasive bladder cancer outcomes: 12‐Month follow‐up data from the international, prospective COVIDSurg Cancer study
par: Cameron E. Alexander, et autres
Publié: (2024)
par: Cameron E. Alexander, et autres
Publié: (2024)
Waiting time in diagnosis and extirpative surgery and association with survival and stage progression in upper tract urothelial carcinomas
par: Fredrik Liedberg, et autres
Publié: (2025)
par: Fredrik Liedberg, et autres
Publié: (2025)
Long‐term outcome of transurethral laser ablation for recurrent non‐muscle invasive bladder cancer: An EORTC risk‐matched study
par: Chase Peng Yun Ng, et autres
Publié: (2025)
par: Chase Peng Yun Ng, et autres
Publié: (2025)
A systematic review of the patient reported outcomes that affect patients with muscle invasive bladder cancer after radical cystectomy and urinary diversion
par: John Lahoud, et autres
Publié: (2024)
par: John Lahoud, et autres
Publié: (2024)
Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
par: Thomas Philip Cahill, et autres
Publié: (2024)
par: Thomas Philip Cahill, et autres
Publié: (2024)
Real‐world use of maintenance bacillus Calmette‐Guérin therapy in patients with non‐muscle‐invasive bladder cancer in Japan: ASUKA study
par: Makito Miyake, et autres
Publié: (2025)
par: Makito Miyake, et autres
Publié: (2025)
Real‐world oncological and toxicity outcomes with the Moscow strain of intravesical BCG for non‐muscle invasive bladder cancer—Implications for global shortage
par: Amandeep Arora, et autres
Publié: (2025)
par: Amandeep Arora, et autres
Publié: (2025)
Hospital variation in the treatment of cT1a renal cancer
par: Cato Caroline Bresser, et autres
Publié: (2026)
par: Cato Caroline Bresser, et autres
Publié: (2026)
Intravesical gemcitabine and docetaxel vs. re‐induction Bacillus Calmette Guerin as first‐line salvage therapy for non‐muscle invasive bladder cancer
par: Kylie Yen‐Yi Lim, et autres
Publié: (2025)
par: Kylie Yen‐Yi Lim, et autres
Publié: (2025)
Health utility value of overactive bladder in Japanese older adults
par: Takashi Yoshioka, et autres
Publié: (2024)
par: Takashi Yoshioka, et autres
Publié: (2024)
Outcomes of Aquablation in BPH with bladder stones: Analysis of the ICARUS database
par: Joshua D. Cabral, et autres
Publié: (2026)
par: Joshua D. Cabral, et autres
Publié: (2026)
Urinary microbiota diversity and composition in patients with advanced renal cell cancer
par: Frederico Leal, et autres
Publié: (2026)
par: Frederico Leal, et autres
Publié: (2026)
Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
par: Jonathon Dawson, et autres
Publié: (2024)
par: Jonathon Dawson, et autres
Publié: (2024)
Exploring patient and clinician opinions, perspectives and acceptance of the use of artificial intelligence in the histological diagnosis of prostate cancer
par: Lisa Browning, et autres
Publié: (2025)
par: Lisa Browning, et autres
Publié: (2025)
Extended versus limited pelvic lymph node dissection and long‐term outcomes in high‐risk prostate cancer before radiotherapy
par: Georgios Daouacher, et autres
Publié: (2026)
par: Georgios Daouacher, et autres
Publié: (2026)
Impact of pre‐stenting and bladder dranaige on intrapelvic pressure during retrograde intrarenal surgery
par: Sezgin Yeni, et autres
Publié: (2025)
par: Sezgin Yeni, et autres
Publié: (2025)
Reduced p63 expression is linked to unfavourable prognosis in muscle‐invasive urothelial carcinoma of the bladder
par: Kira Furlano, et autres
Publié: (2024)
par: Kira Furlano, et autres
Publié: (2024)
Muscle matters: Skeletal muscle index and body mass index impact on complications and survival in renal cancer
par: Alexander Hintze Hillers, et autres
Publié: (2024)
par: Alexander Hintze Hillers, et autres
Publié: (2024)
Documents similaires
-
Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
par: Arjun Pon Avudaiappan, et autres
Publié: (2024) -
Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review
par: Hugo Klempfner, et autres
Publié: (2024) -
The potential role of precision medicine to alleviate racial disparities in prostate, bladder and renal urological cancer care
par: Kunal K. Sindhu, et autres
Publié: (2024) -
Comparing fluorodeoxyglucose positron emission tomography with computed tomography in staging for nodal and distant metastasis in urothelial/bladder cancer
par: Mohammed Al‐Zubaidi, et autres
Publié: (2024) -
Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
par: Muhammad Haider, et autres
Publié: (2025)